دورية أكاديمية

Demonstration of the Rationale for Therapeutic Drug Monitoring of Isavuconazole: A Case Report with a Lung Transplant Recipient

التفاصيل البيبلوغرافية
العنوان: Demonstration of the Rationale for Therapeutic Drug Monitoring of Isavuconazole: A Case Report with a Lung Transplant Recipient
المؤلفون: Eliška Dvořáčková, Andrea Zajacová, Jan Havlín, Eva Klapková, Robert Lischke, Ondřej Slanař, Martin Šíma
المصدر: Prague Medical Report, Vol 124, Iss 4, Pp 444-448 (2023)
بيانات النشر: Karolinum Press, 2023.
سنة النشر: 2023
المجموعة: LCC:Medicine
LCC:Medicine (General)
مصطلحات موضوعية: Medicine, Medicine (General), R5-920
الوصف: Mucormycosis is a rare invasive fungal disease diagnosed in immunocompromised patients, including those with diabetes or iron overload, and in patients treated for hematological malignancies or after transplantation. Isavuconazole is a triazole antifungal effective against Mucorales with good tolerability, but with potential for relatively high interindividual variability in pharmacokinetics. This report demonstrates the case of a lung transplant recipient treated with isavuconasole that exhibits a very long elimination half-life of 159 hours, and discusses the practical implications of this finding for dosage adjustment and need for therapeutic drug monitoring.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2336-2936
1214-6994
23362936
Relation: https://pmr.lf1.cuni.cz/124/4/0444/; https://doaj.org/toc/1214-6994; https://doaj.org/toc/2336-2936
DOI: 10.14712/23362936.2023.34
URL الوصول: https://doaj.org/article/6b4f03535b3c4ed2afec2b5fbe90460d
رقم الأكسشن: edsdoj.6b4f03535b3c4ed2afec2b5fbe90460d
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:23362936
12146994
DOI:10.14712/23362936.2023.34